Proven immune markers continue to protect their relevance for clinical determination-making in breast most cancers treatment with even prolonged meanings. Estrogen receptor (ER) level should not only be classified in good or negative. Small ER degrees ?10% of labeled cells ought to be managed in another way (LoE 1a/A/In the past++). Tumors with sma